Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Eur Urol. 2013 Jan 11;65(4):683–689. doi: 10.1016/j.eururo.2013.01.003

Table 1.

Characteristics of men with prostate cancer in the Health Professionals Follow-up Study (1993–2000) and the Physicians’ Health Study (1982–1992)

Combined cohort HPFS PHS
No. of cases 963 700 263
Age at blood draw, yr, mean (SD) 64.7 (7.6) 65.8 (7.4) 61.7 (7.5)
Age at diagnosis, yr, mean (SD) 69.1 (7.3) 68.9 (7.3) 69.6 (7.5)
Follow-up, yr, mean (SD) 12.0 (4.9) 11.6 (3.8) 13.0 (6.8)
Gleason score, no. (%)
 2–6 467 (54) 353 (53) 114 (56)
 7 296 (34) 238 (36) 58 (29)
 8–10 103 (12) 73 (11) 30 (15)
 Missing 97 36 61
TNM stage, no. (%)
 T1/T2 753 (81) 575 (85) 178 (72)
 T3 118 (13) 81 (12) 37 (15)
 T4/N1/M1 55 (6) 22 (3) 33 (13)
 Missing 37 22 15
Smoking status, no. (%)
 Never 418 (45) 310 (46) 108 (41)
 Past 468 (50) 335 (50) 133 (51)
 Current 53 (6) 31 (5) 22 (8)
 Missing 24 24 0
BMI, kg/m2, no. (%)
 <25 445 (46) 293 (42) 152 (58)
 25–29 435 (45) 335 (48) 100 (38)
 ≥30 83 (9) 72 (10) 11 (4)
Physical activity, no. (%)
 Low 354 (37) 288 (41) 66 (25)
 Moderate 349 (36) 202 (29) 147 (57)
 High 257 (27) 210 (30) 47 (18)
 Missing 3 0 3
Deaths, no. (%) 421 (44) 246 (35) 175 (67)
Deaths from PCa, no. (%) 134 (14) 72 (10) 62 (24)
“Lethal” PCa, no. (%) 148 (15) 82 (12) 66 (25)

BMI = body mass index; HPFS = Health Professionals Follow-up Study; PCa = prostate cancer; PHS = Physicians’ Health Study; SD = standard deviation.

1

Percentages may not add to 100% due to rounding.